Sword said in a Feb. 6 news release that with Mr. Broussard’s expertise, the company will “accelerate its efforts to expand access to its innovative care model and reinforce its position as the leader in AI care.”
“What drew me to Sword is its innovative approach — blending AI-powered care models with expert clinical guidance to set a new standard for accessible, effective care delivery,” Mr. Broussard said in the release.
He stepped down as Humana’s chief executive on July 1 after serving in the role since 2011. In October, he became a venture partner for Define Ventures, a venture capital firm focused on early-stage health tech companies.
